{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T11:12:16Z","timestamp":1722597136352},"reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T00:00:00Z","timestamp":1461369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"DOI":"10.1007\/s00520-016-3222-2","type":"journal-article","created":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T05:15:05Z","timestamp":1461388505000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pay attention to cardiac remodeling in cancer cachexia"],"prefix":"10.1007","author":[{"given":"Yawen","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,23]]},"reference":[{"key":"3222_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","volume":"5","author":"S Haehling von","year":"2014","unstructured":"von Haehling S, Anker SD (2014) Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014. J Cachexia Sarcopenia Muscle 5:261\u2013263","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3222_CR2","first-page":"00128.2014","volume-title":"Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia","author":"AM Shum","year":"2015","unstructured":"Shum AM, Fung DC, Corley SM, McGill MC, Bentley N, Tan TC, Wilkins MR, Polly P (2015) Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia. Physiolgenomics, Physiol Genomics, p. 00128.2014"},{"key":"3222_CR3","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","volume":"35","author":"J Springer","year":"2014","unstructured":"Springer J, Tschirner A, Haghikia A, von Haehling S, Lal H, Grzesiak A, Kaschina E, Palus S, Potsch M, von Websky K, Hocher B, Latouche C, Jaisser F, Morawietz L, Coats AJ, Beadle J, Argiles JM, Thum T, Foldes G, Doehner W, Hilfiker-Kleiner D, Force T, Anker SD (2014) Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. Eur Heart J 35:932\u2013941","journal-title":"Eur Heart J"},{"key":"3222_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7861\/clinmedicine.6-2-140","volume":"6","author":"GD Stewart","year":"2006","unstructured":"Stewart GD, Skipworth RJ, Fearon KC (2006) Cancer cachexia and fatigue. Clin Med 6:140\u2013143","journal-title":"Clin Med"},{"key":"3222_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1072-7515(03)00382-X","volume":"197","author":"N MacDonald","year":"2003","unstructured":"MacDonald N, Easson AM, Mazurak VC, Dunn GP, Baracos VE (2003) Understanding and managing cancer cachexia. J Am Coll Surg 197:143\u2013161","journal-title":"J Am Coll Surg"},{"key":"3222_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13539-014-0136-z","volume":"5","author":"N Ebner","year":"2014","unstructured":"Ebner N, Steinbeck L, Doehner W, Anker SD, von Haehling S (2014) Highlights from the 7th cachexia conference: muscle wasting pathophysiological detection and novel treatment strategies. J Cachexia Sarcopenia Muscle 5:27\u201334","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"3222_CR7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MAJ.0000000000000511","volume":"350","author":"T Yoshida","year":"2015","unstructured":"Yoshida T, Delafontaine P (2015) Mechanisms of cachexia in chronic disease states. Am J Med Sci. 350(4):250\u2013256","journal-title":"Am J Med Sci."},{"key":"3222_CR8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.nut.2012.02.005","volume":"28","author":"UN Das","year":"2012","unstructured":"Das UN (2012) Can cancer cachexia be prevented\/treated? Nutrition 28:844\u2013848","journal-title":"Nutrition"},{"key":"3222_CR9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/BJ20112024","volume":"446","author":"S Lokireddy","year":"2012","unstructured":"Lokireddy S, Wijesoma IW, Bonala S, Wei M, Sze SK, McFarlane C, Kambadur R, Sharma M (2012) Myostatin is a novel tumoral factor that induces cancer cachexia. Biochem J 446:23\u201336","journal-title":"Biochem J"},{"key":"3222_CR10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1186\/1471-2407-14-828","volume":"14","author":"P Mondello","year":"2014","unstructured":"Mondello P, Lacquaniti A, Mondello S, Bolignano D, Pitini V, Aloisi C, Buemi M (2014) Emerging markers of cachexia predict survival in cancer patients. BMC Cancer 14:828","journal-title":"BMC Cancer"},{"key":"3222_CR11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.molmed.2013.02.006","volume":"19","author":"SK Das","year":"2013","unstructured":"Das SK, Hoefler G (2013) The role of triglyceride lipases in cancer associated cachexia. Trends Mol Med 19:292\u2013301","journal-title":"Trends Mol Med"},{"key":"3222_CR12","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/JOE-15-0170","volume":"226","author":"MC Mendes","year":"2015","unstructured":"Mendes MC, Pimentel GD, Costa FO, Carvalheira JB (2015) Molecular and neuroendocrine mechanisms of cancer cachexia. J Endocrinol 226:R29\u2013R43","journal-title":"J Endocrinol"},{"key":"3222_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/01635581.2015.976318","volume":"67","author":"P Mondello","year":"2015","unstructured":"Mondello P, Mian M, Aloisi C, Fama F, Mondello S, Pitini V (2015) Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options. Nutr Cancer 67:12\u201326","journal-title":"Nutr Cancer"},{"key":"3222_CR14","doi-asserted-by":"crossref","unstructured":"Baldwin C (2015) The effectiveness of nutritional interventions in malnutrition and cachexia. Proc Nutr Soc:1\u20138","DOI":"10.1017\/S0029665115002311"},{"key":"3222_CR15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.critrevonc.2014.02.005","volume":"91","author":"TR Balstad","year":"2014","unstructured":"Balstad TR, Solheim TS, Strasser F, Kaasa S, Bye A (2014) Dietary treatment of weight loss in patients with advanced cancer and cachexia: a systematic literature review. Crit Rev Oncol Hematol 91:210\u2013221","journal-title":"Crit Rev Oncol Hematol"},{"key":"3222_CR16","doi-asserted-by":"crossref","unstructured":"Madeddu C, Mantovani G, Gramignano G, Maccio A (2015) Advances in pharmacologic strategies for cancer cachexia. Expert Opin Pharmacother 16(14):2163\u201377","DOI":"10.1517\/14656566.2015.1079621"},{"issue":"9","key":"3222_CR17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ctrv.2015.09.002","volume":"41","author":"A Esposito","year":"2015","unstructured":"Esposito A, Criscitiello C, Gelao L, Pravettoni G, Locatelli M, Minchella I, Di Leo M, Liuzzi R, Milani A, Massaro M, Curigliano G (2015) Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist. Cancer Treat Rev 41(9):793\u2013797","journal-title":"Cancer Treat Rev"},{"key":"3222_CR18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cvr\/cvr060","volume":"90","author":"KK Baskin","year":"2011","unstructured":"Baskin KK, Taegtmeyer H (2011) Taking pressure off the heart: the ins and outs of atrophic remodelling. Cardiovasc Res 90:243\u2013250","journal-title":"Cardiovasc Res"},{"key":"3222_CR19","first-page":"1321","volume":"39","author":"M Tian","year":"2011","unstructured":"Tian M, Asp ML, Nishijima Y, Belury MA (2011) Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice. Int J Oncol 39:1321\u20131326","journal-title":"Int J Oncol"},{"key":"3222_CR20","first-page":"347","volume":"37","author":"M Tian","year":"2010","unstructured":"Tian M, Nishijima Y, Asp ML, Stout MB, Reiser PJ, Belury MA (2010) Cardiac alterations in cancer-induced cachexia in mice. Int J Oncol 37:347\u2013353","journal-title":"Int J Oncol"},{"key":"3222_CR21","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1054\/bjoc.2001.1696","volume":"84","author":"P Costelli","year":"2001","unstructured":"Costelli P, De Tullio R, Baccino FM, Melloni E (2001) Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia. Br J Cancer 84:946\u2013950","journal-title":"Br J Cancer"},{"key":"3222_CR22","doi-asserted-by":"crossref","first-page":"H685","DOI":"10.1152\/ajpheart.00106.2015","volume":"309","author":"RD Devine","year":"2015","unstructured":"Devine RD, Bicer S, Reiser PJ, Velten M, Wold LE (2015) Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia. Am J Physiol Heart Circ Physiol 309:H685\u2013H691","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3222_CR23","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3892\/ijo.2013.1893","volume":"42","author":"ND Manne","year":"2013","unstructured":"Manne ND, Lima M, Enos RT, Wehner P, Carson JA, Blough E (2013) Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin\/+ mouse. Int J Oncol 42:2134\u20132140","journal-title":"Int J Oncol"},{"key":"3222_CR24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ajpath.2010.12.009","volume":"178","author":"A Wysong","year":"2011","unstructured":"Wysong A, Couch M, Shadfar S, Li L, Rodriguez JE, Asher S, Yin X, Gore M, Baldwin A, Patterson C, Willis MS (2011) NF-kappaB inhibition protects against tumor-induced cardiac atrophy in vivo. Am J Pathol 178:1059\u20131068","journal-title":"Am J Pathol"},{"key":"3222_CR25","first-page":"1239","volume":"30","author":"R Moore-Carrasco","year":"2007","unstructured":"Moore-Carrasco R, Busquets S, Almendro V, Palanki M, Lopez-Soriano FJ, Argiles JM (2007) The AP-1\/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia. Int J Oncol 30:1239\u20131245","journal-title":"Int J Oncol"},{"key":"3222_CR26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13539-013-0116-8","volume":"4","author":"EC Hinch","year":"2013","unstructured":"Hinch EC, Sullivan-Gunn MJ, Vaughan VC, McGlynn MA, Lewandowski PA (2013) Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice. J Cachexia Sarcopenia Muscle 4:287\u2013293","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3222_CR27","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-10-3145","volume":"71","author":"PF Cosper","year":"2011","unstructured":"Cosper PF, Leinwand LA (2011) Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Res 71:1710\u20131720","journal-title":"Cancer Res"},{"key":"3222_CR28","first-page":"61","volume":"34","author":"T Fukuda","year":"2009","unstructured":"Fukuda T, Sumi T, Nobeyama H, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O (2009) Multiple organ failure of tumor-bearing rabbits in cancer cachexia is caused by apoptosis of normal organ cells. Int J Oncol 34:61\u201367","journal-title":"Int J Oncol"},{"key":"3222_CR29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.abb.2014.12.026","volume":"567","author":"AI Padrao","year":"2015","unstructured":"Padrao AI, Moreira-Goncalves D, Oliveira PA, Teixeira C, Faustino-Rocha AI, Helguero L, Vitorino R, Santos LL, Amado F, Duarte JA, Ferreira R (2015) Endurance training prevents TWEAK but not myostatin-mediated cardiac remodelling in cancer cachexia. Arch Biochem Biophys 567:13\u201321","journal-title":"Arch Biochem Biophys"},{"key":"3222_CR30","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1007\/s11033-012-1867-6","volume":"39","author":"MY Ren","year":"2012","unstructured":"Ren MY, Sui SJ (2012) The role of TWEAK\/Fn14 in cardiac remodeling. Mol Biol Rep 39:9971\u20139977","journal-title":"Mol Biol Rep"},{"key":"3222_CR31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurjhf\/hfp042","volume":"11","author":"C Bergamini","year":"2009","unstructured":"Bergamini C, Cicoira M, Rossi A, Vassanelli C (2009) Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail 11:444\u2013452","journal-title":"Eur J Heart Fail"},{"key":"3222_CR32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/ars.2009.2818","volume":"12","author":"J Marin-Corral","year":"2010","unstructured":"Marin-Corral J, Fontes CC, Pascual-Guardia S, Sanchez F, Olivan M, Argiles JM, Busquets S, Lopez-Soriano FJ, Barreiro E (2010) Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats. Antioxid Redox Signal 12:365\u2013380","journal-title":"Antioxid Redox Signal"},{"key":"3222_CR33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2013.10.022","volume":"170","author":"Y Elkina","year":"2013","unstructured":"Elkina Y, Palus S, Tschirner A, Hartmann K, von Haehling S, Doehner W, Mayer U, Coats AJ, Beadle J, Anker SD, Springer J (2013) Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia. Int J Cardiol 170:160\u2013166","journal-title":"Int J Cardiol"},{"key":"3222_CR34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.lfs.2010.12.010","volume":"88","author":"H Xu","year":"2011","unstructured":"Xu H, Crawford D, Hutchinson KR, Youtz DJ, Lucchesi PA, Velten M, McCarthy DO, Wold LE (2011) Myocardial dysfunction in an animal model of cancer cachexia. Life Sci 88:406\u2013410","journal-title":"Life Sci"},{"key":"3222_CR35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020424","volume":"6","author":"C Muhlfeld","year":"2011","unstructured":"Muhlfeld C, Das SK, Heinzel FR, Schmidt A, Post H, Schauer S, Papadakis T, Kummer W, Hoefler G (2011) Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart. PLoS One 6:e20424","journal-title":"PLoS One"},{"key":"3222_CR36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1620\/tjem.211.121","volume":"211","author":"O Nevruz","year":"2007","unstructured":"Nevruz O, Yokusoglu M, Uzun M, Demirkol S, Avcu F, Baysan O, Koz C, Cetin T, Sag C, Ural AU, Isik E (2007) Cardiac autonomic functions are altered in patients with acute leukemia, assessed by heart rate variability. Tohoku J Exp Med 211:121\u2013126","journal-title":"Tohoku J Exp Med"},{"key":"3222_CR37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/fca.12.73","volume":"9","author":"A Colombo","year":"2013","unstructured":"Colombo A, Cardinale D (2013) Using cardiac biomarkers and treating cardiotoxicity in cancer. Futur Cardiol 9:105\u2013118","journal-title":"Futur Cardiol"},{"key":"3222_CR38","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.clinbiochem.2013.04.029","volume":"46","author":"E Danese","year":"2013","unstructured":"Danese E, Montagnana M, Giudici S, Aloe R, Franchi M, Guidi GC, Lippi G (2013) Highly-sensitive troponin I is increased in patients with gynecological cancers. Clin Biochem 46:1135\u20131138","journal-title":"Clin Biochem"},{"key":"3222_CR39","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","volume":"301","author":"H Tsutsui","year":"2011","unstructured":"Tsutsui H, Kinugawa S, Matsushima S (2011) Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301:H2181\u2013H2190","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3222_CR40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/chf.12018","volume":"19","author":"J Popat","year":"2013","unstructured":"Popat J, Rivero A, Pratap P, Guglin M (2013) What is causing extremely elevated amino terminal brain natriuretic peptide in cancer patients? Congest Heart Fail 19:143\u2013148","journal-title":"Congest Heart Fail"},{"key":"3222_CR41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.coc.0000256101.04404.b0","volume":"30","author":"SC Burjonroppa","year":"2007","unstructured":"Burjonroppa SC, Tong AT, Xiao LC, Johnson MM, Yusuf SW, Lenihan DJ (2007) Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload. Am J Clin Oncol 30:287\u2013293","journal-title":"Am J Clin Oncol"},{"issue":"23","key":"3222_CR42","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/heartjnl-2015-307848","volume":"101","author":"N Pavo","year":"2015","unstructured":"Pavo N, Raderer M, Hulsmann M, Neuhold S, Adlbrecht C, Strunk G, Goliasch G, Gisslinger H, Steger GG, Hejna M, Kostler W, Zochbauer-Muller S, Marosi C, Kornek G, Auerbach L, Schneider S, Parschalk B, Scheithauer W, Pirker R, Drach J, Zielinski C, Pacher R (2015) Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. Heart 101(23):1874\u20131880","journal-title":"Heart"},{"key":"3222_CR43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lfs.2014.11.029","volume":"125","author":"CR Alves","year":"2015","unstructured":"Alves CR, Da CT, Da PN, Brum PC (2015) Aerobic exercise training as therapy for cardiac and cancer cachexia. Life Sci 125:9\u201314","journal-title":"Life Sci"},{"key":"3222_CR44","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ijc.28128","volume":"133","author":"KT Murphy","year":"2013","unstructured":"Murphy KT, Chee A, Trieu J, Naim T, Lynch GS (2013) Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia. Int J Cancer 133:1234\u20131246","journal-title":"Int J Cancer"},{"key":"3222_CR45","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/j.ijcard.2013.05.063","volume":"168","author":"J Springer","year":"2013","unstructured":"Springer J, Tschirner A, Hartman K, von Haehling S, Anker SD, Doehner W (2013) The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy. Int J Cardiol 168:3527\u20133531","journal-title":"Int J Cardiol"},{"key":"3222_CR46","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1016\/j.ijcard.2013.04.150","volume":"168","author":"S Palus","year":"2013","unstructured":"Palus S, von Haehling S, Flach VC, Tschirner A, Doehner W, Anker SD, Springer J (2013) Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia. Int J Cardiol 168:3412\u20133418","journal-title":"Int J Cardiol"},{"key":"3222_CR47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, Rosenfeld R, Chen Q, Boone T, Simonet WS, Lacey DL, Goldberg AL, Han HQ (2010) Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142:531\u2013543","journal-title":"Cell"},{"key":"3222_CR48","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/01635581.2011.563032","volume":"63","author":"S Shadfar","year":"2011","unstructured":"Shadfar S, Couch ME, McKinney KA, Weinstein LJ, Yin X, Rodriguez JE, Guttridge DC, Willis M (2011) Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer 63:749\u2013762","journal-title":"Nutr Cancer"},{"key":"3222_CR49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cardiores.2006.08.018","volume":"73","author":"S Haehling von","year":"2007","unstructured":"von Haehling S, Doehner W, Anker SD (2007) Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 73:298\u2013309","journal-title":"Cardiovasc Res"},{"key":"3222_CR50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","volume":"121","author":"S Haehling von","year":"2009","unstructured":"von Haehling S, Lainscak M, Springer J, Anker SD (2009) Cardiac cachexia: a systematic overview. Pharmacol Ther 121:227\u2013252","journal-title":"Pharmacol Ther"},{"key":"3222_CR51","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/eurheartj\/ehs181","volume":"34","author":"TM Suter","year":"2013","unstructured":"Suter TM, Ewer MS (2013) Cancer drugs and the heart: importance and management. Eur Heart J 34:1102\u20131111","journal-title":"Eur Heart J"},{"key":"3222_CR52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pcad.2010.05.004","volume":"53","author":"DL Mann","year":"2010","unstructured":"Mann DL, Krone RJ (2010) Cardiac disease in cancer patients: an overview. Prog Cardiovasc Dis 53:80\u201387","journal-title":"Prog Cardiovasc Dis"},{"key":"3222_CR53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3322\/caac.21192","volume":"63","author":"JA Greer","year":"2013","unstructured":"Greer JA, Jackson VA, Meier DE, Temel JS (2013) Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin 63:349\u2013363","journal-title":"CA Cancer J Clin"},{"key":"3222_CR54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmjspcare-2012-000227","volume":"3","author":"D Mauri","year":"2013","unstructured":"Mauri D, Tsiara A, Valachis A, Kalopita K, Tsali L, Tolis P, Polyzos NP (2013) Cancer cachexia: global awareness and guideline implementation on the web. BMJ Support Palliat Care 3:155\u2013160","journal-title":"BMJ Support Palliat Care"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3222-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-016-3222-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3222-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:01:01Z","timestamp":1567814461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-016-3222-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,23]]},"references-count":54,"alternative-id":["3222"],"URL":"https:\/\/doi.org\/10.1007\/s00520-016-3222-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,23]]}}}